Search Results - "Mackenzie, Gerardo"
-
1
Curcumin formulated in solid lipid nanoparticles has enhanced efficacy in Hodgkin's lymphoma in mice
Published in Archives of biochemistry and biophysics (15-06-2018)“…Curcumin reduces Hodgkin's lymphoma (HL) cell growth in vitro, but its unfavorable pharmacokinetics highlight the need for novel in vivo delivery systems…”
Get full text
Journal Article -
2
Chlorogenic acid combined with epigallocatechin-3-gallate mitigates D-galactose-induced gut aging in mice
Published in Food & function (20-03-2023)“…Chlorogenic acid (CGA) and epigallocatechin-3-gallate (EGCG) are major polyphenolic constituents of coffee and green tea with beneficial health properties. In…”
Get more information
Journal Article -
3
A high-fat diet induces changes in mesenteric adipose tissue accelerating early-stage pancreatic carcinogenesis in mice
Published in The Journal of nutritional biochemistry (01-09-2024)“…•A high-fat diet accelerates pancreatic carcinogenesis by activating ERK and STAT3.•A high-fat diet promotes immune cell infiltration in the pancreas.•A…”
Get full text
Journal Article -
4
EGCG sensitizes chemotherapeutic-induced cytotoxicity by targeting the ERK pathway in multiple cancer cell lines
Published in Archives of biochemistry and biophysics (15-10-2020)“…Epigallocatechin-3-gallate (EGCG), a major polyphenol component of green tea, presents anticancer efficacy. However, its exact mechanism of action is not…”
Get full text
Journal Article -
5
Ketogenic Diets in Pancreatic Cancer and Associated Cachexia: Cellular Mechanisms and Clinical Perspectives
Published in Nutrients (15-09-2021)“…Pancreatic ductal adenocarcinoma (PDAC) is an aggressive and extremely therapy-resistant cancer. It is estimated that up to 80% of PDAC patients present with…”
Get full text
Journal Article -
6
Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models
Published in Food & function (14-11-2018)“…Numerous studies propose that epigallocatechin-3-gallate (EGCG), an abundant polyphenol in green tea, has anti-cancer properties. However, its mechanism of…”
Get more information
Journal Article -
7
The inhibitory effect of ECG and EGCG dimeric procyanidins on colorectal cancer cells growth is associated with their actions at lipid rafts and the inhibition of the epidermal growth factor receptor signaling
Published in Biochemical pharmacology (01-05-2020)“…[Display omitted] Colorectal cancer (CRC) is one of the most common cancers worldwide. Epidemiological studies indicate that consumption of fruits and…”
Get full text
Journal Article -
8
Targeting Glycolysis with Epigallocatechin-3-Gallate Enhances the Efficacy of Chemotherapeutics in Pancreatic Cancer Cells and Xenografts
Published in Cancers (05-10-2019)“…Pancreatic cancer is a complex disease, in need of new therapeutic approaches. In this study, we explored the effect and mechanism of action of…”
Get full text
Journal Article -
9
Pancreatic cancer: A critical review of dietary risk
Published in Nutrition research (New York, N.Y.) (01-04-2018)“…Pancreatic cancer is a deadly disease. It is estimated that about 90% of pancreatic cancer cases are due to environmental risk factors. Among these,…”
Get full text
Journal Article -
10
Combination of miR‑143 and miR‑506 reduces lung and pancreatic cancer cell growth through the downregulation of cyclin‑dependent kinases
Published in Oncology reports (01-04-2021)“…Lung cancer (LC) and pancreatic cancer (PC) are the first and fourth leading causes of cancer‑related deaths in the US. Deregulated cell cycle progression is…”
Get full text
Journal Article -
11
Phospho-Aspirin (MDC-22) inhibits pancreatic cancer growth in patient-derived tumor xenografts and KPC mice by targeting EGFR: Enhanced efficacy in combination with irinotecan
Published in Neoplasia (New York, N.Y.) (01-02-2022)“…Novel therapeutic strategies are needed in the fight against pancreatic cancer. We have previously documented the chemopreventive effect of MDC-22 in…”
Get full text
Journal Article -
12
(-)-Epigallocatechin-3-gallate mitigates cyclophosphamide-induced intestinal injury by modulating the tight junctions, inflammation and dysbiosis in mice
Published in Food & function (15-11-2021)“…Cyclophosphamide (CTX) is an antitumor drug commonly used to treat various cancer types. Unfortunately, its toxic side effects, including gastrointestinal (GI)…”
Get more information
Journal Article -
13
Impact of dietary fat composition and quantity in pancreatic carcinogenesis: Recent advances and controversies
Published in Nutrition research (New York, N.Y.) (01-04-2021)“…A significant number of pancreatic cancer cases are due to modifiable risk factors, with many being attributed to increased body fatness. This has sparked…”
Get full text
Journal Article -
14
Targeting mitochondrial STAT3 with the novel phospho-valproic acid (MDC-1112) inhibits pancreatic cancer growth in mice
Published in PloS one (01-05-2013)“…New agents are needed to treat pancreatic cancer, one of the most lethal human malignancies. We synthesized phospho-valproic acid, a novel valproic acid…”
Get full text
Journal Article -
15
-
16
Epigallocatechin-3-Gallate (EGCG) Suppresses Pancreatic Cancer Cell Growth, Invasion, and Migration partly through the Inhibition of Akt Pathway and Epithelial-Mesenchymal Transition: Enhanced Efficacy when Combined with Gemcitabine
Published in Nutrients (09-08-2019)“…Most pancreatic cancers are usually diagnosed at an advanced stage when they have already metastasized. Epigallocatechin-3-gallate (EGCG), a major polyphenolic…”
Get full text
Journal Article -
17
DHA-SBT-1214 Taxoid Nanoemulsion and Anti-PD-L1 Antibody Combination Therapy Enhances Antitumor Efficacy in a Syngeneic Pancreatic Adenocarcinoma Model
Published in Molecular cancer therapeutics (01-11-2019)“…The goal of this study was to evaluate combination of a novel taxoid, DHA-SBT-1214 chemotherapy, in modulating immune checkpoint marker expression and…”
Get full text
Journal Article -
18
Hepatic safety profile of pancreatic cancer‑bearing mice fed a ketogenic diet in combination with gemcitabine
Published in Oncology letters (01-11-2023)“…Ketogenic diets (KDs) are actively being evaluated for their potential anticancer effects. Although KDs are generally considered safe, their safety profile…”
Get full text
Journal Article -
19
Hyaluronic acid nanoparticle-encapsulated microRNA-125b repolarizes tumor-associated macrophages in pancreatic cancer
Published in Nanomedicine (London, England) (01-10-2021)“…To investigate a novel strategy to target tumor-associated macrophages and reprogram them to an antitumor phenotype in pancreatic adenocarcinoma (PDAC). M2…”
Get full text
Journal Article -
20
A Ketogenic Diet in Combination with Gemcitabine Mitigates Pancreatic Cancer-Associated Cachexia in Male and Female KPC Mice
Published in International journal of molecular sciences (28-06-2023)“…Cancer-associated cachexia (CAC) is a critical contributor to pancreatic ductal adenocarcinoma (PDAC) mortality. Thus, there is an urgent need for new…”
Get full text
Journal Article